Dr. Carlos E. Vigil is a board-certified Hematologist and Oncologist, with a background in clinical trial development in malignancies both in clinical practice and at a large pharmaceutical company. His clinical focus lies in leukemia and stem cell transplant, cancer research at the molecular biology level, and improving patient access to these services.
Academically, Dr. Vigil has served as Assistant Professor at Northwestern University, where he led the creation of a Myelodysplastic Syndrome clinic and became the inpatient clinical lead at Northwestern University. He also served as Assistant Professor in the Division of Hematology/Oncology and Bone Marrow Transplant and Clinicaxl Director in leukemia research at the University of Iowa, where he facilitated the growth of the research portfolio, bringing access to novel therapies in the Midwest. Dr. Vigil also served in leadership roles at the Division of Clinical Oncology for severe neutropenic and stem cell transplant at Instituto Nacional de Enfermedades Neoplasicas, in Lima Peru.
Dr. Vigil completed fellowships in Hematology/Oncology at H. Lee Moffitt Cancer Center; Leukemia at M.D. Anderson Cancer Center; and Bone Marrow and Stem Cell at Vanderbilt University Medical Center. He has also served as a member of the International Consortium on Acute Leukemia and the Venous Thromboembolism Task Force at Roswell Park Cancer Institute.
Given his vast contribution, Dr. Vigil has been awarded honors from the National Cancer Institute of Peru, the American Society of Hematology, and American Society of Clinical Oncology.
